Streetbeat News

Price Targets

MRTX

B. Riley Securities analyst Kalpit Patel has downgraded Mirati Therapeutics from Buy to Neutral and lowered the price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 1:13 pm

VRTX

Morgan Stanley analyst Matthew Harrison has maintained an Equal-Weight rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raised the price target from $352 to $359.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 1:04 pm

OUT

Morgan Stanley analyst Benjamin Swinburne has maintained an Equal-Weight rating on Outfront Media (NYSE:OUT) but lowered the price target from $15 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 1:02 pm

LAMR

Morgan Stanley analyst Benjamin Swinburne has maintained an Equal-Weight rating on Lamar Advertising (NASDAQ:LAMR) but lowered the price target from $100 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 1:00 pm

CAG

Morgan Stanley analyst Pamela Kaufman has maintained an Equal-Weight rating on Conagra Brands (NYSE:CAG) but lowered the price target from $37 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:59 pm

ARMK

Morgan Stanley analyst Toni Kaplan has maintained an Equal-Weight rating on Aramark (NYSE:ARMK) and lowered the price target from $44 to $27.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:58 pm

STZ

Barclays analyst Lauren Lieberman maintains an Overweight rating on Constellation Brands (NYSE:STZ) but lowers the price target from $294 to $280.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:46 pm

CAG

Barclays analyst Andrew Lazar has maintained an Overweight rating on Conagra Brands (NYSE:CAG) but lowered the price target from $39 to $31.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:45 pm

PAG

Benchmark analyst Michael Ward has reiterated a 'Buy' rating on Penske Automotive Group (NYSE:PAG) and maintained a price target of $196.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:42 pm

LYV

Benchmark analyst Matthew Harrigan has reiterated a 'Buy' rating on Live Nation Entertainment (NYSE:LYV) and maintained a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:40 pm